Cardiac transplantation in Friedreich Ataxia: Extended follow-up

被引:15
作者
McCormick, Ashley [1 ]
Shinnick, Julianna [1 ]
Schadt, Kim [1 ,2 ]
Rodriguez, Rose [3 ]
Addonizio, Linda [3 ]
Hirano, Michio [4 ]
Perlman, Susan [5 ]
Lin, Kimberly Y. [2 ,6 ]
Lynch, David R. [1 ,2 ]
机构
[1] Childrens Hosp Philadelphia, Dept Pediat & Neurol, Philadelphia, PA 19104 USA
[2] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
[3] Columbia Univ Coll Phys & Surg, Dept Pediat & Cardiol, 630 W 168th St, New York, NY 10032 USA
[4] Columbia Univ, Dept Neurol, Med Ctr, New York, NY USA
[5] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA
[6] Childrens Hosp Philadelphia, Dept Pediat & Cardiol, Philadelphia, PA 19104 USA
关键词
Friedreich Ataxia (FRDA); Guanine-guanine-adenine (GAA) triplet repeat; Cardiomyopathy; Ejection fraction; Cardiac transplantation; CARDIOMYOPATHY; PROGRESSION; THERAPY; HEART;
D O I
10.1016/j.jns.2017.01.027
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Friedreich Ataxia (FRDA) is an autosomal recessive neurodegenerative disorder most commonly caused by guanine-adenine-adenine (GAA) trinucleotide repeat expansions in both alleles of the FXN gene. Although progressive ataxia remains the hallmark clinical feature, patients with FRDA are at high risk of developing cardiomyopathy, often resulting in premature death. There is no specific treatment for FRDA-associated cardiomyopathy; even in advanced cardiac failure cardiac transplantation is not commonly pursued. This case series describes extended follow-up of three FRDA cases with end-stage heart failure but mild neurologic disease who underwent successful heart transplantation. We also review and examine the ethical considerations for heart transplantation in the setting of neurodegenerative disease. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:471 / 473
页数:3
相关论文
共 18 条
  • [1] Towards gene therapy for the cardiomyopathy associated with Friedreich's ataxia
    Belbellaa, Brahim
    Puccio, Helene
    [J]. M S-MEDECINE SCIENCES, 2014, 30 (10): : 842 - 845
  • [2] Measuring the Rate of Progression in Friedreich Ataxia: Implications for Clinical Trial Design
    Friedman, Lisa S.
    Farmer, Jennifer M.
    Perlman, Susan
    Wilmot, George
    Gomez, Christopher M.
    Bushara, Khalaf O.
    Mathews, Katherine D.
    Subramony, S. H.
    Ashizawa, Tetsuo
    Balcer, Laura J.
    Wilson, Robert B.
    Lynch, David R.
    [J]. MOVEMENT DISORDERS, 2010, 25 (04) : 426 - 432
  • [3] HEWER RL, 1969, BRIT HEART J, V31, P5
  • [4] Ivak P., 2016, J HEART LUNG TRANSPL
  • [5] Friedreich's ataxia presenting after cardiac transplantation
    Leonard, H
    Forsyth, R
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2001, 84 (02) : 167 - 168
  • [6] The Registry of the International Society for Heart and Lung Transplantation: Thirty-third Adult Heart Transplantation Report-2016; Focus Theme: Primary Diagnostic Indications for Transplant
    Lund, Lars H.
    Edwards, Leah B.
    Dipchand, Anne I.
    Goldfarb, Samuel.
    Kucheryavaya, Anna Y.
    Levvey, Bronwyn J.
    Meiser, Bruno
    Rossano, Joseph W.
    Yusen, Roger D.
    Stehlik, Josef
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (10) : 1158 - 1169
  • [7] Lynch DR, 2012, EXPERT REV CARDIOVAS, V10, P767, DOI [10.1586/erc.12.57, 10.1586/ERC.12.57]
  • [8] Friedreich ataxia - Effects of genetic understanding on clinical evaluation and therapy
    Lynch, DR
    Farmer, JM
    Balcer, LJ
    Wilson, RB
    [J]. ARCHIVES OF NEUROLOGY, 2002, 59 (05) : 743 - 747
  • [9] Friedreich ataxia: The clinical picture
    Pandolfo, Massimo
    [J]. JOURNAL OF NEUROLOGY, 2009, 256 : 3 - 8
  • [10] Clinical features of Friedreich's ataxia: classical and atypical phenotypes
    Parkinson, Michael H.
    Boesch, Sylvia
    Nachbauer, Wolfgang
    Mariotti, Caterina
    Giunti, Paola
    [J]. JOURNAL OF NEUROCHEMISTRY, 2013, 126 : 103 - 117